Suchergebnisse - "Grau-Pujol, Berta"

PubPharm (27)

21

Pre-exposure prophylaxis with hydroxychloroquine for high-risk healthcare workers during the COVID-19 pandemic: A structured summary of a study protocol for a multicentre, double-blind randomized controlled trial

enthalten in: Trials | 2020

von Grau-Pujol, B. | Camprubí, D. | Marti-Soler, H. | +3

22

Pre-exposure prophylaxis with hydroxychloroquine for high-risk healthcare workers during the COVID-19 pandemic: A structured summary of a study protocol for a multicentre, double-blind randomized controlled trial

enthalten in: Trials | 2020

von Grau-Pujol, B. | Camprubí, D. | Marti-Soler, H. | +3

23

Role of DNA-detection-based tools for monitoring the soil-transmitted helminth treatment response in drug-efficacy trials

enthalten in: PLoS neglected tropical diseases | 2020

von Gandasegui, J. | Martínez-Valladares, M. | Grau-Pujol, B. | +8

24

Lack of efficacy of standard doses of ivermectin in severe COVID-19 patients

enthalten in: PloS one | 2020

von Camprubí, D. | Almuedo-Riera, A. | Martí-Soler, H. | +6

ErratumIn: PLoS One. 2022 May 12;17(5):e0268667. - PMID 35551297

25

Frequency and distribution of neglected tropical diseases in Mozambique : a systematic review

enthalten in: Infectious diseases of poverty | 2019

von Grau-Pujol, B. | Massangaie, M. | Cano, J. | +4

26

Frequency and distribution of neglected tropical diseases in Mozambique: a systematic review

enthalten in: Infectious diseases of poverty | 2019

von Grau-Pujol, B. | Massangaie, M. | Cano, J. | +4

27

Anti-V3/Glycan and Anti-MPER Neutralizing Antibodies, but Not Anti-V2/Glycan Site Antibodies, Are Strongly Associated with Greater Anti-HIV-1 Neutralization Breadth and Potency

enthalten in: Journal of virology | 2015

von Jacob, R. | Moyo, T. | Schomaker, M. | +3